Discussions | 16 Mar 2015 Epo short peptide...anyone know about this? Matthew Cohen Does anyone know anything more about this?When will this study be completed?Any way to get access to this agent now? http://www.ncats.nih.gov/research/rare-diseases/bridgs/projects/jm4.html Comment1 commentRecommendBookmarkWatch Comments The study is not listed on clinicaltrials.gov which is supposed to list every phase 2 and above clinical trial in the United States. This suggests that the study is in a very early stage, perhaps pre-clinical. I suggest you contact the individuals listed as "lead collaborators" at Rutgers: Peter Dowling, M.D.; Stuart Cook, M.D.; and Robert Heary, M.D.